Buying a Shockwave device is not just a matter of comparing product specifications or pricing. For medical professionals, the more important question is whether the technology can become a meaningful part of patient care: something your team understands, uses confidently, explains clearly to patients, and integrates into your broader treatment strategy. This long-term perspective shows why the buying process is more nuanced than it may first appear.
This guide focuses on two Shockwave technologies: Radial Pressure Wave (EPAT® or Extracorporeal Pulse Activation Technology) and Focused Shockwave (ESWT or Extracorporeal Shockwave Therapy). Together, these technologies can support multimodal, non-invasive treatment strategies across musculoskeletal and soft tissue applications.
Shockwave is supported by decades of research and earns an 80%+ patient satisfaction rate, but selecting the right device for your practice is not always straightforward. A strong buying process should help you look beyond the initial purchase and understand what it will take to achieve clinical proficiency, patient impact, and long-term ROI.
This guide walks through the key questions medical professionals should ask when evaluating Shockwave technology, choosing the right manufacturer and distribution partner, and building the foundation for long-term success.
New to Shockwave? It may help to start with a foundational overview of how Shockwave therapy works, what it is used for, and how it supports tissue repair and regeneration.
The Right (and Wrong) Questions to Ask Early About Shockwave
For medical professionals evaluating Shockwave, the earliest questions should focus on the bigger picture: what you are investing in, how the technology will fit into your continuum of care, and what it will take to use it successfully over time.
When practices focus too narrowly on finding the lowest-cost option or comparing technical details in isolation, they risk making a purchase that never reaches its full clinical or economic potential.
A stronger evaluation looks beyond initial purchase price alone to consider what will help your team use Shockwave consistently to improve patient outcomes and drive ROI from your investment over the long term.
The questions below are a great place to start.
Early Questions to Ask When Evaluating a Potential Shockwave Partner
Each of these questions reflects a real implementation challenge that practices need to solve in order to get the most out of Shockwave. A thoughtful, proactive provider should not only be prepared to answer them clearly, but should also have proven strategies, resources, and support systems already in place.
- What does successful implementation look like in a practice like mine?
Shockwave adoption looks different depending on your specialty, patient population, workflows, and treatment goals. The right partner should help you define what success looks like in your specific practice, not just explain what the device can do in general.
- What does the journey to clinical proficiency look like, including sample timelines?
Shockwave is not difficult to learn, but it does require hands-on familiarity, protocol knowledge, and clinical judgment. A strong partner should be able to explain how practices typically progress from initial onboarding to confident, consistent use.
- What introductory training is included, and how is it delivered over time?
Initial training should give your team a practical foundation for using the technology safely and effectively. It should also be structured in a way that supports real-world adoption, rather than overwhelming the team with a single one-time session.
- What types of ongoing education and training are offered?
As your practice gains experience, your use of Shockwave should continue to expand and mature. Ongoing education helps providers refine technique, broaden appropriate use cases, and stay aligned with evolving research and best practices.
- How does this integrate into my current care pathways?
Shockwave should not sit outside your existing model of care. A meaningful evaluation should consider where it fits clinically, when it should be introduced, which patients are appropriate candidates, and how it complements the treatments you already provide.
- What support and education exists after the sale?
The most important phase often begins after the purchase. Post-sale support helps ensure your team continues building confidence, avoids underutilization, and has somewhere to turn as clinical, operational, or patient communication questions arise.
- Can I speak to medical professionals who are successfully using this system?
Peer insight can help you understand how the technology performs in real-world practices. Conversations with experienced users can clarify practical questions around adoption, patient response, workflow, and long-term value.
- What tech and service support is offered?
Reliable service matters because downtime, uncertainty, or unresolved technical issues can disrupt patient care and staff confidence. Practices should understand who provides support, how quickly questions are addressed, and what resources are available when issues arise.
- What research and studies have been published using the manufacturer’s technology?
Not every device marketed with “wave” terminology has the same evidence base behind it. Evaluating the research connected to the manufacturer’s technology helps you understand whether the platform is supported by meaningful clinical evidence.
- Beyond the initial investment, what is the cost to maintain the device? Are there any consumables? How often do they need to be replaced and what’s the cost?
A complete financial evaluation should include more than the purchase price. Maintenance expectations, consumables, replacement schedules, warranties, and service needs all affect the true long-term cost of ownership.
Questions You Should NOT Be Leading With
Certain early questions can derail your Shockwave evaluation if they become the center of the decision-making process:
- What’s the price and is it negotiable?
- What’s the cheapest option?
- Can I buy it online or on Amazon?
These are not irresponsible questions in themselves. Cost, purchasing options, and total investment all matter.
The issue is that leading with these questions can shift the evaluation away from what will actually determine whether Shockwave succeeds in your practice — and whether you are buying the right device to deliver the best possible medical treatment to your patients.
The Risk of Focusing Exclusively on Price
The real risk is ending up with a marginally cheaper device that your team is not prepared to use effectively. If the technology is underutilized, poorly integrated, unsupported, or difficult to explain to patients, the lower upfront price may not translate into better long-term value. In fact, this bare-bones approach can contribute to missed outcomes, inconsistent use, and a device that never becomes a meaningful part of patient care.
A stronger evaluation weighs price alongside the practical realities of implementation.
A strong partner will want to help you think through the clinical, operational, educational, and economic realities of adoption before you buy. The wrong partner may have little interest in that nuance, focusing instead on pushing the cheapest possible solution out the door.
The Price Comparison Trap (And What to Do Instead)
Shockwave systems can vary widely in cost, and it is natural for medical professionals to compare pricing as part of the buying process. But even beyond the risks outlined above, focusing on the cheapest option is limiting for a very simple reason: price alone is a poor predictor of value.
That is especially true in a market where many companies have added “wave” to a product name and positioned themselves within the broader Shockwave category. Validated Shockwave devices are backed by 30+ years of clinical evidence, but these imitator devices may lack the same level of published research supporting their use.
A superficial, quick-scan side-by-side price comparison can be misleading. Why? Because it only captures the most obvious first-order costs. For example:
- Upfront device cost: The purchase price is easy to compare, but it does not show whether the system will be supported consistently or effectively.
- Consumables: Applicator tips, coil exchanges, replacement parts, and other use-related costs should absolutely be part of the evaluation. However, they need to be understood in context: how often the device will be used, which treatments your practice plans to offer, what maintenance looks like over time, and whether the system supports enough clinical applications to justify those ongoing costs.
- Warranty: Warranty terms are important, but they are not the same thing as meaningful support. A warranty may tell you what is covered on paper; it does not necessarily tell you how quickly issues are addressed, how accessible technical support is, or whether your partner will help keep the system productive after purchase.
What Actually Determines ROI
ROI depends on what happens once the technology is inside your practice: how often it is used, how confidently it is applied, how well patients understand it, and whether it becomes part of your clinical model rather than an occasional add-on.
- Education and training to achieve clinical confidence: ROI can vary substantially based on whether providers and staff know how to apply the technology appropriately. Proven best practices for training help your team move from owning the device to using it confidently across real patient cases.
- Breadth of treatable conditions backed by research using that brand or device: A stronger research foundation translates directly to broader clinical applications, giving your practice more opportunities to use the technology. That breadth can support higher utilization and make Shockwave relevant to more patients within your existing care model.
- Patient outcomes, retention, and referrals: When patients understand the treatment, respond well, and see value in the care experience, that can strengthen retention and generate word-of-mouth referrals. Clinical confidence and patient communication both play an important role in that process.
- Cash-pay success: For many practices, Shockwave becomes part of a cash-pay or hybrid care model. Success depends on more than pricing the treatment correctly. It requires patient education, clear expectations, staff alignment, and a confident explanation of why the treatment is being recommended.
- Practice differentiation: Shockwave can help a practice stand out by offering a non-invasive, evidence-based treatment option that supports tissue repair and recovery. That differentiation is strongest when the technology is integrated thoughtfully, not treated as a one-off add-on.
All of these factors show why the better question is not only, “What does it cost?” It is, “What will it take for this to become a meaningful part of my practice?” and “How will this help me best help my patients?”
Why the Purchase is Just the Beginning
Many Shockwave purchases fall short not because the practice chose to invest, but because the post-purchase implementation never fully takes shape. The device arrives, the team receives some initial instruction, and then real-world adoption depends on dozens of practical details that are easy to underestimate.
Important inflection points when implementing Shockwave include:
- Expanding beyond limited indication use: Without a clear implementation plan, a practice may only use Shockwave for one familiar condition, such as plantar fasciitis. With the right support, providers can expand appropriately as confidence grows, increasing clinical utility, patient impact, and long-term ROI.
- Fully using applicators, tips, and accessories: A system may have broader capabilities than the team is actually using. Learning how and when to use different applicators, tips, and accessories can improve treatment flexibility and help the practice get more value from the technology it already owns.
- Positioning Shockwave early in the care plan: When Shockwave is saved only as a last resort, patients may never understand where it could fit earlier in their treatment journey. Introducing it at the right point in the care plan can support more proactive patient conversations and help providers recommend the technology with clearer clinical purpose.
- Educating patients: Patient conversations can become uncomfortable when the team does not have a clear explanation for why Shockwave is being recommended. When providers and staff are aligned around the clinical rationale, expected treatment course, and patient benefits, the conversation becomes educational rather than transactional.
- Explaining cost and coverage clearly: Framing options simply as “covered” versus “not covered” can confuse patients, especially when deductibles, copays, and other out-of-pocket costs still apply. Clearer language helps patients compare treatment options more accurately and understand the value of the recommended care.
- Building consistent protocols: Without a shared approach, treatment decisions can vary too much across providers, conditions, and patient scenarios. Protocol refinement helps create more consistency, supports clinical confidence, and gives the team a clearer framework for appropriate use.
- Creating staff alignment: If the team does not understand the treatment, workflow, or patient communication strategy, adoption becomes harder to sustain. When staff are trained, informed, and bought in, Shockwave is easier to integrate into daily practice and easier to present confidently to patients.
In short, the practices that want to achieve the greatest possible ROI on their investment will not treat Shockwave as a simple plug-and-play modality. Using Shockwave is not rocket science, but there is a real proficiency curve to fully integrating Shockwave into your continuum of care.
That is why the purchase is only the starting point. Long-term success depends on practical post-sale support: ongoing education, protocol refinement, real-world application guidance, and peer connection with providers who are actively using Shockwave in patient care.
Learn more about how to incorporate Shockwave into a regenerative medicine practice.
What to Look for in a Shockwave Partner
The implementation nuances outlined above show why who you purchase from matters as much as the device itself. By this point in the buying process, the question is no longer just whether a device can deliver Shockwave. The more important question is whether the provider can help your practice keep progressing after the system is installed: from basic use, to consistent protocols, to broader clinical confidence.
1. A Commitment to Ongoing Education (Not One-Time Training)
Initial training can show your team how to operate the device. It cannot, by itself, teach a practice how to keep expanding appropriate use, refine technique across different conditions, or build Shockwave into a mature treatment strategy.
Look for a partner that supports learning beyond onboarding. That means ongoing education opportunities, structured clinical resources, and guidance that helps your team evolve protocols as confidence grows.
Without that continued development, Shockwave often stays limited to the first few indications a provider feels comfortable treating. With the right educational support, practices are better positioned to expand usage thoughtfully and apply the technology with greater consistency over time.
2. Access to Emerging Trends & Research-Supported Use Cases
Shockwave is not a static modality. The research, treatment applications, and clinical protocols continue to evolve, which means practices need more than a device manual and a few starter indications.
A strong partner should help you stay connected to that evolution. That includes sharing relevant research, explaining how new evidence may apply in practice, and helping translate clinical developments into usable treatment strategies. The value is not simply knowing that more studies exist. It is understanding what the evidence may mean for patient selection, protocol development, multimodal care, and expanded use over time.
This is part of how practices move beyond treating one familiar condition with one device. With the right educational support and peer connection, providers can build confidence across a broader range of MSK and regenerative applications while staying grounded in research-supported use cases.
3. A Clear Strategy for Multimodal Approach
Many experienced Shockwave users are not thinking in terms of a single device for a single condition. They are thinking about how different energy-based technologies can work together as part of a broader treatment strategy, especially for complex or chronic musculoskeletal conditions.
A knowledgeable partner should be able to help you understand how Radial Pressure Wave, Focused Shockwave, and Extracorporeal Magnetotransduction Therapy (EMTT) may fit together in practice. That includes identifying which use cases make sense for your patient population, how treatments may be sequenced, which patient profiles may benefit from a combined approach, and what evidence supports those decisions.
The goal is to build a clear clinical strategy around:
- When each modality is appropriate
- How they complement one another
- How they can support better outcomes within your existing model of care.
Learn more about how to integrate an optimal combined EMTT-Shockwave approach.
4. Direct Access to Thought Leaders
Materials and training resources are useful, but some of the most valuable learning comes from experienced medical professionals who are actively using Shockwave in patient care. Those conversations can surface the practical details that do not always fit neatly into a protocol document: how providers think through difficult cases, adjust techniques, sequence treatments, and avoid common pitfalls.
Look for a partner that can connect you with clinicians and thought leaders who are already applying Shockwave at a high level. Access to case discussion, real-world insights, advanced techniques, and both U.S. and international leaders in the field can shorten the learning curve and help your practice keep improving as your experience grows.
5. A True Clinical Community (Not Just Customer Support)
One of the most valuable parts of a strong Shockwave partnership is access to other providers who are working through similar clinical and operational questions. Customer support can help resolve a specific issue. A clinical community can help providers keep learning, compare real-world experiences, and refine how the technology is used over time.
Look for a partner that provides access to:
- An engaged network of medical professionals using the technology
- Peer-to-peer learning and case sharing
- Ongoing dialogue around outcomes, challenges, and innovation
- Practical resources that support both clinical use and patient communication
For example, CuraMedix offers the CuraMedix Insiders’ Exchange, a private, community-based education platform for providers who have invested in STORZ Medical Shockwave and EMTT devices directly from CuraMedix. The platform includes protocol resources, application guides, videos, quick tables, on-demand webinars, live and recorded courses, discussion forums, patient-facing marketing materials, technical resources, troubleshooting tips, maintenance support, and opportunities for providers to ask questions and share best practices.
That kind of community matters because you are not learning in isolation. Providers can gain confidence faster, keep refining their approach, and learn from others who are actively applying the technology in patient care. The difference between stagnation and growth is often who you are learning alongside.
5. Post-Sale Support That Drives Utilization
All of these partner qualities ladder up to one core outcome: consistent, confident use of the technology. The real risk is not only choosing the wrong system. It is investing in a capable system and never fully using what it can do.
A high-value partner helps your practice keep moving after the initial purchase. That means support that is tied to utilization, not just troubleshooting. As your team gains experience, the right partner should help you:
- Expand appropriate indications over time
- Stay aligned with current research
- Continue progressing toward clinical mastery
- Get answers when service or technical questions arise
This depth of support helps prevent Shockwave from becoming a narrowly used device in the corner of the practice. Instead, it supports the larger goal: making the technology a practical, trusted, and sustainable part of patient care.
Learn More About Investing in Shockwave for Your Practice
Ready to compare Shockwave options for your practice? CuraMedix can help you evaluate the technology, clinical applications, implementation considerations, and long-term support behind the purchase.
As the leading U.S. distributor of STORZ Medical technology, CuraMedix offers a complete suite of Radial Pressure Wave, Focused Shockwave, and Extracorporeal Magnetotransduction Therapy (EMTT® ) devices for medical professionals looking to expand non-invasive treatment options. Our team supports practices with education, training, service, and practical guidance designed to help turn device adoption into confident clinical use.
Reach out to CuraMedix to discuss your goals, compare technology options, and learn which Shockwave solution may be the right fit for your practice.
